Under construction – not a live service
Sign in

Myelodysplastic syndromes: open trials in Brazil

4 open trials have a site in Brazil. Registry data; only the trial team decides who can take part.

  • NCT06499285

    A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

    Trial Treatment · Phase 3 · Takeda

    Hosptial Erasto Gaertner, Curitiba · FundaAAo Doutor Amaral Carvalho, Jaú · Instituto Joinvilense de Hematologia e Oncologia, Joinville · Hospital Mae de Deus, Clinical Research Unit - Cancer Institute, Porto Alegre · Porto Alegre Clinical Hospital (HCPA), Porto Alegre · Pontifical University Of Rio Grande Do Sul (PUCRS) - St. Luke Hospital, Porto Alegre · Americas Institute, Rio de Janeiro · Cepho- Fmabc, Santo André · Sao Jose do Rio Preto Regional Faculty of Medicine Foundation, São José do Rio Preto · Santa Casa of Mercy of Santos, São Paulo · Portuguese Charity of Sao Paulo, Clinical Hematology / Oncology Center, São Paulo · Hospital A.C.Camargo ("Antonio Prudente" Foundation), São Paulo

    Registry updated 2026-11-06

  • NCT07422480

    A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions

    Trial Treatment · Phase 3 · Takeda

    Hospital Amaral Carvalho (HAC), Jaú · Centro de Hematologia e Oncologia (CHO), Joinville · Porto Alegre Clinical Hospital (HCPA), Porto Alegre · Hospital Mae de Deus, Clinical Research Unit - Cancer Institute, Porto Alegre · D'OR Institute for Research and Education, Salvador · Irmandade da Santa Casa da Misericordia de Santos (ISCMS), Santos · Portuguese Charity of Sao Paulo, Clinical Hematology / Oncology Center, São Paulo · Hospital 9 de Julho (Rede Americas/DASA), São Paulo

    Registry updated 2026-11-06

  • NCT06465953

    Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation

    Trial Treatment · Phase 3 · Institut de Recherches Internationales Servier

    Liga Paranaense de Combate ao Cancer - Hospital Erasto Gaertner, Curitiba · Centro de Pesquisas Clínicas da Fundação Doutor Amaral Carvalho, São Paulo · Instituto Nacional do Câncer, São Paulo · Real E Benemerita Associacao Portuguesa de Sao Paulo, São Paulo · Casa de Saude Santa Marcelina, São Paulo · Hospital das Clinicas da Faculdade de Medicina da USP, São Paulo · Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein, São Paulo · Centro de Pesquisa Clínica - Hospital Nove de Julho, São Paulo

    Registry updated 2026-09-03

  • NCT06299462

    PTCy and ATG for MSD and MUD Transplants

    Trial Treatment · Phase 1/2 · Instituto Nacional de Cancer, Brazil

    Instituto Nacional de Câncer, Rio de Janeiro

    Registry updated 2025-02-25

All Myelodysplastic syndromes trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Under construction, not live – Myelodysplastic syndromes trials in Brazil – Frontlight Research